Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Transfusion Medicine Reviews|October 24, 2022
Advances in Acquired Hemophilia AJacqueline N Poston, Rebecca Kruse-JarresInternational Journal of Hematology|April 12, 2019
Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case seriesJacqueline N Poston, Terry B GernsheimerJournal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Controversies Regarding Use of Myeloid Growth Factors in LeukemiaJacqueline N Poston, Pamela S BeckerBlood|September 6, 2023
How I treat von Willebrand disorders in older adultsJacqueline N Poston, Rebecca Kruse-JarresClinical Medicine Insights. Blood Disorders|April 7, 2018
The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedJacqueline N Poston, Russell Dorer, David M AboulafiaHaemophilia : the Official Journal of the World Federation of Hemophilia|August 4, 2022
Prevalence of comorbid conditions among older males with haemophilia receiving care in haemophilia treatment centers in the United StatesJ Michael Soucie, Binh Le, Brandi Dupervil, et al.Vox Sanguinis|February 22, 2020
Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN® centresJacqueline N Poston, Jessica Sugalski, Terry B Gernsheimer, et al.The Annals of Pharmacotherapy|March 22, 2025
Time to Target Anti-Xa Level in Obese Vs Nonobese Patients Using an Adjusted Body Weight Heparin Infusion Protocol for the Treatment of Venous ThromboembolismMary K Eibye, Jacqueline N Poston, Amanda G Kennedy, et al.Blood Advances|August 12, 2025
Efficacy of Eculizumab Discontinuation in Atypical Hemolytic Uremic Syndrome: A Systematic Review and Meta-analysisAmy Hockman, Sydney Anuskiewicz, Emily Brennan, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 20, 2017
Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in ratsBiji Mathew, Jacqueline N Poston, John C Dreixler, et al.Pageof 3